Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Natera, Inc.

Natera, Inc. (NTRA) Stock Overview

Explore Natera, Inc.’s financial performance, market position, analyst ratings, and future outlook.

NTRA●NASDAQ
HealthcareMedical - Diagnostics & Research
$332.03
$7.19(2.21%)
U.S. Market opens in 62h 3m

Natera, Inc. (NTRA)

Meyka AI Score

Z

Key Financials

Market Cap47.6B
P/E Ratio-242.60
EPS (TTM)$-1.32
ROE-0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$314.45
3 Months$267.15
1 Year Target$233.54

NTRA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Natera, Inc. (NASDAQ: NTRA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Natera, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NTRA on the NASDAQ shows an RSI of 72.08, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $233.54 for the NASDAQ listing.

Key metrics behind Natera, Inc.'s NASDAQ-traded stock include a P/E ratio of -242.60 and a market capitalization of 47.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of NTRA on the NASDAQ.

Price Performance (NASDAQ: NTRA)

1-Day Change
2.21%
5-Day Change
7.80%
1-Month Change
24.27%
3-Month Change
63.008%
6-Month Change
56.53%
Year-to-Date (YTD) Change
44.93%
1-Year Change
105.02%
3-Year Change
504.57%
5-Year Change
199.99%
All-Time (Max) Change
1744.61%

Contact Information

https://www.natera.com
650 249 9090
13011 McCallen Pass Building A, Austin, TX, 78753

Company Facts

61,380 Employees
IPO DateJul 1, 2015
CountryUS
Actively Trading

Frequently Asked Questions